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Background: Transmission of the human immunodeficiency virus (HIV) among incarcerated injection drug users
(IDU) is a health epidemic in the Islamic Republic of Iran. Triangular clinics (TCs) were established in prisons as a
harm reduction measure to decrease the risk of HIV transmission and other blood-borne infections. The objective of
this study was to assess the immediate outcomes of one TC among male IDUs in Iran’s Rajaee-Shahr prison.
Methods: This study was conducted in two stages between 2003 and 2005. In the preparatory stage, focus group
data was collected to update the prison’s TC education and medical interventions and construct the self-report
questionnaire. In stage two, 150 male IDUs were recruited in a closed cohort study design to assess the immediate
outcome of the TC. Participants were measured at baseline and followed up to six months to measure their drug
use, attitude toward and knowledge of high risk behaviours, serological conversion for HIV, HBV and HCV, and
engagement in risky behaviors. The TC outcomes were determined through random urine analysis testing, a
self-administered questionnaire and behaviour report cards, and viral infection testing.
Results: The findings of the urine analyses indicated a minimal yet consistent decrease in drug use over the six
months. The pre and post- self-administered questionnaire data relayed a modest change in IDU risky behaviours
associated with sexual practices; this was greater in comparison to the knowledge and attitude measures. It was
determined that age may have a detrimental effect as may viral infections (HIV and HBV) on knowledge, attitude
and behavior change. Both education and employment may have a protective effect. Data collected from the
self-report behaviour cards similarly showed a modest reduction in high risk practices. At the six month follow-up,
only one case became HIV positive, 9 HCV and 17 HBV.
Conclusions: Considering that HIV is concentrated among Iranian prisoners who inject drugs at a high level, the
results of this study indicate that TCs are a possible effective intervention. However, many prisoners continued with
risky behaviors even if they were participating in harm reduction measures, such as methadone maintenance
therapy.
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To address the IDU and HIV epidemic we need “to
break the silence and change attitudes of prisoners and
policy makers and [have] collaboration all around”.
-Dr. Afshar, Director General of Health Services for the
Iranian Prison Organization at the 2004 International
AIDS Conference.
With a population of over 75 million people in Iran,
the number of individuals abusing drugs is estimated to
be over one million, with approximately 200,000 to
300,000 injection drug users (IDU) [1,2]. At present, the
human immunodeficiency virus (HIV) is highly concen-
trated among IDUs [3]. Over the past several years there
has been an increase in HIV cases originating from sexual
transmission in the general population [3], however, the
large majority of new cases (65-79%) remain among IDU’s
sharing needles [3-5]. With a growing proportion of young
people making up the Iranian population and an increase
in the availability of drugs, including a mounting relation-
ship between amphetamine-type stimulant use and high
risk sexual practices, the country is vulnerable to an in-
crease in the number of new drug users, including those
engaged in injecting and other high risk behaviours [5]. In
turn, there is potential for a dramatic increase in the
prevalence of HIV, as well as the hepatitis B virus (HBV)
and hepatitis C virus (HCV) [6]. The most recent (2012)
United Nations AIDS progress report by the Islamic
Republic of Iran acknowledged that if the current HIV
epidemic among IDUs is left unattended, it has the poten-
tial to turn into a generalized population epidemic [3].
Acknowledging the direct linkage between IDU and
the spread of HIV, Iran committed to attempts to con-
trol the spread of the disease at the 2003, 2008 and 2011
United Nations General Assembly Special Sessions on
HIV/AIDS. The latest data relay that “[m]easures taken
over the past ten years have successfully slowed the pro-
gression of the epidemic among injection drug users”,
but the HIV rate among IDUs remains at around 15%
and varies across the country [3]. A surveillance survey
in 2010 in Iran further revealed that “among those who
had injected drugs over the last month, 36.9% had used
a non-sterile needle, and 12.6% had practiced shared
injection” [7]. Controlling the spread of HIV within
Iranian penitentiaries is a particular concern with their
concentration of IDUs as well as high risk behaviours.
Foremost, the majority of incarcerated IDUs, some HIV
positive, will reintegrate back into their communities,
and this is a particular concern for the spread of HIV
and other transmitted diseases [8].
A 2006 study by Zamani et al. reported that 94% of
IDUs in Iran have been incarcerated at least once in
their lifetime. Among them, 28% reported using injec-
tion drugs at least once within the prison; of these, 82%
reported using a shared injection device, with 36% ofthese individuals being HIV-positive [9]. A 2007 study
by the same authors found that in their site-specific
study of Karaj Central prison [10] in Iran, 42% of pris-
oners reported to use intravenous drugs before their
incarceration. A more recent 2013 study, reporting on
2009 data from a sample of 27 Iranian prisons, con-
cluded that the prevalence of HIV among the prisoner
population is 2.1%, and 8.1% among those who have a his-
tory of IDU [3]. They also found that only 24% of pris-
oners reported condom use during their last vaginal/anal
sexual encounter in prison, 12.9% reported being tattooed
while incarcerated, and only one in five had sufficient
knowledge of the routes of HIV transmission and pre-
ventative measures [8]. Such high risk behaviours among
prisoners both before and during their incarceration have
turned Iranian prisons into highly prospective environ-
ments for acquiring HIV.
In response, triangular clinics (TCs) surfaced in Iranian
prisons at the turn of the 21st century [11] as part of a co-
ordinated, country-wide approach to the dual epidemic of
HIV and IDU [12]. Iran has a long-standing commitment
to supply reduction efforts, that is, largely enforcement ef-
forts that aim to disrupt the manufacturing and distribu-
tion of drugs, with a history of severe punishment for
drug dealing. This coincides with the correctional system’s
harsh and overcrowded prison conditions, detainment of
political dissidents, and carrying out of prisoner execu-
tions. However, with a high rate of IDU and an emerging
HIV health epidemic, coupled with lessons learned from
other countries, demand reduction efforts that focus on
treatment and prevention were introduced to reduce indi-
viduals’ needs for drugs. Harm reduction clinics initiated
in the community; these are drop-in centres in drug-
ridden neighborhoods where former drug abusers assist
with offering “needles, methadone, treatment for sexually
transmitted diseases, AIDS tests and other medical care to
their peers” [13]. The clinics transitioned into triangular
clinics in the prison environment and similarly offer harm
reduction measures. Both clinic types were embraced as
both pragmatic and progressive in consideration of the
country’s general conservative social climate [11,14]. In
fact, Iran’s concept of the TC is largely unique across the
globe [15]. In Canada and the United states, for example,
the prison systems do not offer needle exchange even
though IDU in these systems too is a concern; it is fre-
quently a part of the fabric of prison life [16].
In line with Iran’s promotion of a participatory and
proactive approach to control the HIV epidemic [3], TCs
acknowledge the mutual role of the prisoner, the staff
and the prison environment. Triangular Clinics aim to:
(1) improve information to affected groups regarding
HIV/AIDS/drug abuse; (2) improve information to staff
regarding HIV/AIDS/drug abuse, (3) provide access to
facilities regarding harm reduction, and (4) improve the
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These aims support the Health Belief Model (HBM) and
its focus on informing beliefs (knowledge) and attitudes to
eventually change behaviour, and specifically within the
HV/AIDS field. “Within a harm reduction context, the
HBM provides a systematic framework for examining the
reasoning behind an individual’s choice to decrease, main-
tain or increase their high risk behaviour” [17]. It is well
established in the prevention and treatment literature that
handing out clean needles in isolation from other support
services, for example, is inadequate for sustainable behav-
iour change [18].
The TCs provide a variety of harm reduction services in-
cluding counseling, education, referral services, and treat-
ment such as methadone maintenance therapy (MMT)
[19]. For example, MMT is currently available to opioid-
dependent prisoners in over half of the 230 prisons and
correctional settings in Iran [10]. With the introduction of
TCs and MMT, the total number of prisoners taking part
in methadone therapy increased from 100 in 2002 to more
than 25,000 in 2009 [1,20]. Since their introduction they
have also expanded to address STIs in addition to HIV/
AIDS. However, still, relatively little research has been
undertaken to assess the outcome of TC’s on behavior
change. The aim of this study is to assess the immediate
outcome of a TC on behavior change among injection
drug users incarcerated in Rajaee-Shahr prison in Iran.
Drawing on available data, the outcome indicators include
(1) drug use, (2) change in attitude toward and belief
about (knowledge) high risk behaviours, (3) serological
conversion (HIV, HCV and HBV), and (4) engagement in
risky behaviors (e.g., syringe exchange, condom use).
Methods
Setting and sample
In order to assess the immediate outcome of the TC as a
health intervention in an Iranian prison, this study
funded by the World Health Organization was under-
taken in Rajaee-Shahr prison between 2003 and 2005.
The lapse in time between the data collection and publi-
cation of this paper in part reflects the detailed process
for data release in the country. Ethics for the study was
granted from the World Health Organization, Special
Programme for Research and Training in Tropical Dis-
eases, and the Iran Prisons Organization ethics commit-
tee. Rajaee-Shahr prison is located 70 km northwest of
Tehran (Iran’s capital) in the city of Karaj, has an inmate
population of approximately 3,200 individuals, and is
one of the most crowed and harsh prison environments
in the country [12,20].
The study sample was a closed cohort of 150 incarcer-
ated male injection drug users; the first 150 prisoners who
voluntarily registered in the study were included. Given
the conservative environment of the Iranian correctionalfacility, this was deemed the best method to solicit partici-
pation and is similar to how other topic sensitive studies
have been carried out in the prison system [8]. In order to
be eligible for selection, individuals must: (1) have been
imprisoned for more than four months, (2) not have been
diagnosed with a psychiatric disorder, (3) not have previ-
ously accessed the TC or other harm reduction services in
the prison, and (4) be an injection drug user and willing to
take part in MMT. Verbal informed consent was acquired
from all study participants. For individuals with low liter-
acy, a designated and trained staff member was available




The study was conducted in two stages: (1) the qualita-
tive preparatory stage, and (2) the quantitative outcome
testing stage. The first stage is addressed in detail in this
paper and sets the necessary context for understanding
the operation of a TC. In this preparatory stage, three
focus groups were held. The groups were comprised of
eight to ten men imprisoned in Rajaee-Shahr prison who
were involved in high risk drug and sexual behaviors
(e.g., needle sharing); all focus groups were held in Farsi
language and lasted approximately two hours. The aim
of this initial step in the study was to gather baseline un-
derstanding about the target group’s knowledge, attitude,
and practices related to IDU, HIV/AIDS, HBV, HCV, un-
safe sexual practices, and other risky behaviors. These
three foci reflect the Health Belief Model, which focuses
on individuals’ attitudes and beliefs in an attempt to ex-
plain and predict health behaviors, in particular sexual
and other high risk taking to prevent the transmission of
HIV [19,21,22]. This data was used to review and revise
the existing TC educational and medical interventions in
Rajaee-Shahr prison as well as to construct the question-
naire for the second step of the study – measuring im-
mediate outcomes.
Stage two
The second stage of the study collected data from all par-
ticipants at baseline and six months following their first at-
tendance at the TC. The questionnaire was designed to
address the key components of the Health Belief Model:
(1) perceived risk (measuring knowledge and attitude),
(2) perceived severity (measuring knowledge and attitude),
(3) perceived benefits (measuring attitude), (4) perceived
barriers (measuring attitude), and (4) cues to action (meas-
uring behaviors). The questionnaire included 75 questions,
measuring knowledge (39 questions), attitude (26 ques-
tions), and practices (10 questions). The content validity of
the questionnaire was assessed through six expert reviews
in the areas of health education, infectious disease, and
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tested for reliability among 40 randomly selected prisoners
representative of the study target group imprisoned at
Rajee-Shahr. With 34 responses, internal consistency of the
questionnaire was measured with Cronbach’s Alpha test,
and the outcome was greater than 74%.
In addition to the questionnaire, at pre-test each par-
ticipant completed a personal history survey, a physical
examination, testing for HIV, HBV and HCV viral infec-
tion, STI testing, and urine analysis for drug residue.
From this, physicians determined the medical needs of
each participant and suggested various treatment options,
including detoxification, STI counseling, and MMT. A
health and education counseling session was held with
each prisoner.
All 150 participants started MMT in groups of 5 to 10
(referred to as the attack phase). Throughout this phase,
participants were closely monitored for several weeks in
an isolated ward of the prison to minimize any unantici-
pated effects of withdrawal and risks due to other drug
use. The prescribed methadone dosage for each partici-
pant was determined by a physician and accounted for
the participant’s health status, drug use history, and
other personal indexes. The daily dosage of methadone
was between 80–125 mg. Following the attack phase,
participants were relocated to the common ward of the
prison where they received a maintenance dose of
methadone (referred to as the loading phase). This phase
was undertaken for a 6-month period, during which all
participants received their daily dosage of methadone
under the direct supervision of a trained health staff
member. This marked the beginning of the outcome
testing of the TC intervention.
After 6 months, the participants completed: (1) ran-
dom urine analysis for opium/heroin residuals via thin-
layer chromatography (TLC) to measure drug use, (2)
the follow-up study questionnaire (to measure practice,
knowledge, and attitude change), and (3) HIV, HBV,
HCV viral infection testing. The study also issued and
collected self-report behavior cards at four equal inter-
vals over the 6 month period (at the end of months 2, 3,
4 and 5). The study benefited from applying these cards
in two ways: to remind participants of the high risk for
contracting viral infections (i.e., HIV, HBV, HCV) with
risky behaviors (e.g., sharing sharp instruments such as a
razor, tattooing, injecting drugs, sexual contact without
using a condom), and to collect self-reported engage-
ment in risky behaviours.
Results
Participants
Of the 150 participants enrolled in the study, all re-
ported to be of Iranian and Muslim descent, with 62%
born in the province of Tehran. The mean age was31.4 years (SD = 8.2). Only 21% graduated from high
school or attended university, while 14% identified them-
selves as illiterate. Eleven percent of participants reported
being unemployed at their time of their incarceration.
Fifty percent were single and had never been married, and
of those that were married, 65 had children. The mean
years of drug abuse was 10.97 (SD = 7.6) and the mean
years of injection drug use was 5.39 (SD = 5.21). This
translates into participants reporting to have spent, on
average, a third of their lives abusing drugs (32% of life-
time, SD = 17.08%), with engagement in injection drug use
for approximately one-seventh of their lives (15.98% of
lifetime, SD = 12.75%). A total of 103 participants com-
pleted the full study.
More than 88% of the participants agreed to be tested
for viral infections at the start of the study, of which
42.5% tested positive for HIV, 18.9% for HBV, and 75.9%
for HCV. Ninety percent of participants were screened
for sexually transmitted infections (gonorrhea and syph-
ilis) and all were negative. A urinalysis was performed
on 81% of participants; only one participant tested posi-
tive and for a urinary tract infection. Although the find-
ings of this study are unique to Rajaee-Shahr prison and
therefore not directly transferable to other TCs in the
Iranian correctional system, given the comparable con-
text of HIV, IDU and incarceration across the country,
they can provide important insight.
Stage one
The data collected in the qualitative preparatory stage of
the study was systematically reviewed to recommend
revisions to the current TC educational and medical in-
terventions for high risk groups, primarily IDUs, in the
prison (e.g., cultural adaption). They were originally de-
veloped based on the best available knowledge at the
time and this study was the first attempt to review the
prisoner, staff and prison context for their implementa-
tion. Attention was placed during this stage on prisoner
behavior change. This stage was time intensive because
all interventions needed to be compatible with prison
rules and required staff education.
The amended interventions offered through the TC in-
cluded: counseling and testing for HIV/AIDS and Hepa-
titis; STI and disease examination (i.e., Venereal Disease
Research Laboratory test for syphilis, Fluorescent Trepo-
nemal Antibody-Absorption and Gram Staining for Gon-
orrhea, and Urine Analysis for Urinary Tract Infections),
treatment, and care; harm reduction and related drug
abuse services, including MMT, syringe exchange, and
care and treatment of injection sites; education regarding
HIV/AIDS, STIs, and harm reduction; and other related
services, such as condom distribution, medication, and
treating other diseases such as Tuberculosis. The inclusion
of MMT was based on the finding that heroin was the
Table 1 Opium and/or heroin use during TC intervention
Urine test Test result Frequency Percent
(of total)
Valid percent
1 Negative 7 4.7 18.4
Positive 31 20.7 81.6
Total 38 25.3 100.0
2 Negative 5 3.3 18.5
Positive 22 14.7 81.5
Total 27 18.0 100.0
3 Negative 16 10.7 19.5
Positive 66 44.0 80.5
Total 82 54.7 100.0
4 Negative 20 13.3 21.1
Positive 75 50.0 78.9
Total 95 63.3 100.0
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prison population due to its ease of access, low cost, and
efficiency.Stage two
Drawing on available data, the outcome indicators include:
(1) drug use, (2) change in attitude toward and belief
about (knowledge) high risk behaviours, (3) serological
conversion (HIV, HCV and HBV), and (4) engagement in
risky behaviors (e.g., syringe exchange, condom use).Drug use
Throughout the TC intervention, random urine analysis
using TLC was conducted to detect opium and heroin
residuals, a strong indicator of injection drug use. Com-
pliance was limited with only 64% of participants provid-
ing samples at the four points. Positive drug results for
opium and heroin were high, ranging from 78.9% to 81.6%
of participants (see Table 1). The data does indicate a min-
imal yet consistent decrease over time (from 81.6% to
78.9%), however, this was not significant (p = 0.982).Table 2 Practice, knowledge and attitude change
N Mean (% of maxim
achievable scor
Valid Missing
Knowledge pre-test 104 46 27.17 (0.69.6)
Knowledge post-test 53 97 27.63 (0.70.8)
Attitude pre-test 149 1 76.44 (0.73.5)
Attitude post-test 92 58 75.51 (0.72.6)
Practice pre-test 148 2 11.85 (0.59.2)
Practice post-test 91 59 13.69 (0.68.4)Practice, knowledge and attitude change
Analysis of the pre and post- self-administered question-
naire data relayed that a change in IDU risky behaviours
and associated sexual practices, although modest, was
greater in comparison to knowledge and attitude (see
Table 2) and also had the least respondent variability
among the three components of the HBM. The results
of a paired t-test (see Table 3) similarly revealed reduced
engagement in risky practices following respondents’ TC
attendance (.000). Neither knowledge nor attitude ap-
peared to be affected—positively or negatively.
Applying multiple linear regression to examine a com-
bined knowledge, attitude and behavior (KAB) score, the
only significant determinant was the degree of knowledge,
attitude and behaviour pre-test, adjusting for age, employ-
ment, addiction history, viral infection status, and educa-
tion. This may be partially explained by the size of the
study population and the loss of follow-up participants. It
can, however, be tentatively hypothesized that based on
the coefficients a larger sample size may produce statis-
tical significance.
Additional data analyses relayed that post-intervention
KAB is significantly related to KAB at baseline (P = 0.05)
(see Table 4). Further, individuals with positive test re-
sults in HIV (Beta −5.36) and HBV (Beta −4.48) and also
older in age (Beta −0.16 per 1 year increase in age) had
acquired scores in KAB, although it was not statistically
significant. Age may have an inverse effect on the KAB
score as may viral infections (HIV and HBV). Both edu-
cation and employment may have a positive effect.HIV, HBV and HCV conversion
The findings of the questionnaire relaying a slight reduc-
tion in IDU-related risky behaviour and this is consistent
with the viral infection test results, which showed an
increase in 1 HIV conversion, 21 HBV, and 9 HCV (see
Figure 1). Although comparison data on conversions
prior to the TC are not available, these findings are en-
couraging among a high risk group of IDUs. Recall that
at baseline 43% of respondents tested positive for HIV,
19% HBV and 76% HCV.um
e)









Table 3 Pre and post-test impact of TC on practice,
knowledge and attitude
Variables Sig. (2-tailed)
Knowledge pre and post-test .937
Attitude pre and post-test .687
Behaviour pre and post-test .000
Combined knowledge, attitude and behavior pre
and post-test
.419
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The completion rate for the self-report behaviour cards
documenting the participants’ high risk drug and sexual-
related practices during the TC intervention was limited
(see Table 5). Nonetheless, the data relay that over the
course of the 6 month study, 53% of the study partici-
pants remained free of any risky behaviour after two
months of involvement in the intervention. Engagement
in risky behavior increased throughout the 6 month
period, with only 1.4% of the participants reporting be-
ing risk-free after the total period of the study (i.e.,
6 months) (see Table 6).
More specifically, focusing on HCV converted status
because it had the highest initial viral infection rate
among the prison population and therefore the greatest
availability and accuracy of immediate test results, when
risky practices at any of the four time points during the
6 month TC intervention were tested among participants
who became HCV positive, the data collected on the
self-report behavior cards showed that there was no sig-
nificant difference between the risky behavior of con-
verted cases and others (fisher’s exact test: 2sided = 1.00)
(see Table 7).
Although not identified in the initial study design, two
additional indicators of high risk behavior emerged as
the study progressed. These were the frequency of ab-
scess formation at the injection site, and the number of
drug-related quarrels. According to informal clinical ob-
servations and security records, there was no evidence
of either of these issues among the study participants.Table 4 Knowledge, attitude and behaviour post-test
association with independent factors
Beta coefficient P value
KAB pretest 0.31 0.052
Age −0.16 0.719
Employment 4.48 0.76
Addiction history 0.27 0.521
HIV + infection −5.36 0.383
HBV + infection −4.48 0.483
Education 1.45 0.75This again suggests that there was some reduction in
risky behaviors.
Risky practices index
In acknowledgement of the cultural taboo associated with
intoxicant use in Iran and its potential impact on full dis-
closure in the study, an index for participating in risky
practices related to IDU was created through a combining
of reported shared drug injection equipment and positive
urine analysis. The findings relayed that 71% of partici-
pants engaged in at least one high risk behaviour during
the TC intervention, despite receiving the TC harm reduc-
tion services. With 29% of the sample missing, it is un-
known if any participants were totally free from risky
behavior during the 6 month study period. Overall, par-
ticipation in risky behaviour varied between 93% and 86%
at the four reporting points over the course of the TC
intervention (see Figure 2).
Discussion
The documented number of HIV cases in Iran increased
87% between 2001 and 2007 [23]. The vast majority of
new cases were identified among IDUs [24-26]. The two
key risk factors are imprisonment and the use of con-
taminated injection equipment while incarcerated [9].
Likewise, recent studies of HCV among men incarcer-
ated in Tehran, Iran identified a history of incarceration
to be independently associated with HCV infection [27].
The same was found of HBV and sexually transmitted
diseases [27,45]. The same cannot necessarily be applied
to female prisoners in Iran [28]. A recent study of TCs
in Hamadan province in Iran concluded that the estab-
lishment of TCs is a starting point for organizing IDUs
infected with HIV/AIDS to detect and address their dis-
ease [29]. It is well established that there is a high preva-
lence of high risk behaviors among IDUs [2], but there
remains limited understanding about how to change the
high risk behaviours of incarcerated individuals who in-
ject drugs, including the immediate and long-term out-
comes of TCs.
Although time consuming, it was critical that the first
step in this study focused on generating knowledge about
the prisoner population so that the existing Rajaee-Shahr
TC educational and medical interventions could be appro-
priately modified. For example, it was established that the
low literacy level among the majority of prisoners who
would access the TC needed to be considered in the avail-
able written material. Offering services at the TC that are
tailored to respond foremost to client needs is founda-
tional to a harm reduction philosophy. It was also essential
that baseline characteristics of the prisoner population
were established to undertake step two of the study and
the identification of outcome indicators, such as HIV,
HCV and HBV status, which have been identified as
Figure 1 Viral infection status of study participants before and after TC intervention.
Table 5 Frequency of high risk practices on self-report
behaviour cards
Returned Missing* Total
Time 1 72 78 150
Time 2 57 93 150
Time 3 41 109 150
Time 4 68 82 150
*Includes individuals who did not complete the study.
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drugs in Tehran, Iran [30].
The findings of this study relay that the immediate
outcome of the TC in Rajaee-Shahr prison on behaviour
change among injection drug users is modest. The prem-
ise of the Health Belief Model – that individuals’ attitudes
and beliefs explain and predict health behaviors – did not
support behaviour change over the six-month period. This
does not mean, however, that the TC is ineffective. In fact,
evidence to the contrary was concluded. It should also be
kept in mind that Rajaee-Shahr prison is an institution in
which individuals are sentenced for serious, long-term
crimes and the volunteer sample for this study represents
long-term, high risk IDUs. Consequently, the impact of
harm reduction measures on knowledge and attitude may
be minimal in the sort-term, even though some behavior
was modified. A study by Shams et al. (2011) examined
the impact of harm reduction approaches in Iranian
prisons over a two year period and found there was not an
immediate reduction (after one year/2007) in social behav-
ior across the provincial institutions (e.g., self-harm, drug
abuse, bullying), but that over the long-term (2 years/
2008) there was [20].
Examining this study’s outcome indicators, it was con-
cluded that introducing the TC intervention led to a
minimal decrease in drug use (i.e., opium and heroin),
although it did consistently decrease over the 6 month
period. Once again, the high risk IDU prisoner popula-
tion needs to be considered in interpreting this finding.
This is a particularly important finding given that all
participants in the study were prescribed MMT. Reasons
for the participants’ continued drug use while on MMT
requires exploration, including whether it is in the indi-
vidual’s best interest to be prescribed methadone. Future
studies should investigate MMT dosage guidelines, means
of distribution to combat diversion, and the source ofproblematic drug use within the prison environment in
order to provide the most effective TC harm reduction
intervention.
Although the majority of participants continued their
drug use, there was still some reported decrease in asso-
ciated risky practices, although this was not sustained by
the vast majority of participants over the six month
intervention. With participants reporting long-term drug
use, including IDU, it should not be expected that a swift
change in behavior would occur. Although, a recent study
of prisoners in Ghezel Hesar prison in Tehran, Iran found
that “the rate of injecting in the prison unit … decreased
drastically since introducing the MMT program” [31].
Further examination into the specifics of this intervention
would be useful.
The corresponding absence of change in knowledge and
attitude in the current study may in part be explained by
the primary focus of the TC being on behaviour change,
and the fact that individuals enrolled in the study may
have already had altered beliefs and attitudes based on the
preparatory stage of the study/at baseline. This finding
may also suggest that access to harm reduction services,
including MMT, has the potential to motivate prisoners to
change their behavior without altering their current know-
ledge or attitude. This is an important consideration to
Table 6 Timing of prisoners’ practicing of risky behaviour
Interval End of month Total Engaged in risky behavior Lost Survival Std. error [95% Conf. Int.]
1 2 110 52 0 0.527 0.047 0.43 0.615
2 3 58 14 0 0.40 0.046 0.308 0.489
3 4 44 31 0 0.118 0.030 0.066 0.186
4 5 13 9 4 0.014 0.014 0.004 0.067
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haviors, according to the Health Belief Model, requires
change among all three components. This may in fact help
to explain the lack of sustained behaviour change across
the 6 month study period.
There was no difference found in engagement in risky
behaviour among participants who became HCV posi-
tive during the study and those that did not. This implies
that a ‘one size fits all’ approach to practice change may
not be warranted, which underpins the harm reduction
philosophy of a TC. There is a need for much greater
understanding about the intricacies of prisoners’ lives
and their high risk drug use and sexual practice related
behaviors [32].
It was also found that HIV and HBV positive status as
well as older age may diminish change in knowledge, at-
titude and practices. This may be explained by the feel-
ing of hopelessness that may accompany a positive viral
status and pessimism with older age. This is supported
by the finding that the effect was stronger for HIV infec-
tion. The opposite may be the case for participants with
higher education and employment status. A 2010 survey
of injection drug users in Iran similarly found that edu-
cation greater than high school and permanent employ-
ment were protective factors for HIV transmission [6].
The results of the current study suggest that existing
interventions may not be as effective for extremely high
risk groups like drug injecting prisoners who already are
affected with viral infections and are well informed
given their compromised health status; hence this may
indicate the need for targeted interventions for specific
groups [33].
It is well established that not enough is known about
the high risk behaviors of IDUs in Iran, both generallyTable 7 Practicing of risky behaviors among participants
who became HCV positive during the study
Converted HCV test Total
No Yes
Risky behavior Yes 90 5 95
No 0 0 0
Missing 34 1 35
Total 124 6 130and particularly within prison sub-populations [31,34]. A
baseline study of prisoners in Karaj Central prison, for
example, found that injecting, in comparison to non-
injecting drug-using prisoners, were more likely to have
been tested for HIV infection [10]; this is useful informa-
tion. In measuring the outcome of the TC, the current
study only considered injection drug use and related
risky practices. To further develop the TC, it would be
useful to know more context-specific information, such
as if the TC stimulates change in the extent to which
drug users organize their lives around drug use, how
much drug use is integrated into their lives, and the
ways in which drug use negatively impacts other aspects
of their health [35]. Related, it was determined that the
most frequent viral infection among the participants
was Hepatitis C. This is consistent with other studies of
incarcerated groups [33], and should be given equivalent
attention to HIV in the reduction measures being im-
plemented within TCs.
Given the complex nature of this study, it has four key
limitations. These may in part explain the absence of
concrete findings. First, the attempt to measure both sex
and non-sex related high risk behaviors in the conserva-
tive social environment of a prison setting in Iran has
extreme cultural and religious taboos. This may have
translated into decreased levels of accuracy and compli-
ance with reporting in the study. One means to address
this was the development of a risky practices index
(combined indicator of reported shared drug injection
equipment and positive urine analysis results at the same
sequence). In the future, the development of a less com-
plex and lengthy questionnaire may want to be consid-
ered, as well as observational reporting. Related, focus
was paid to measuring prisoner behavior to the exclu-
sion of considering the mutual role of staff in the TC
and the prison environment (other than in the prepara-
tory phase) in this study. Third, participant retention
was a limitation of the study; it is anticipated that with
an increased, non-punitive presence of the TC clinic
within the prison environment as time progresses, pris-
oners may be willing to report their IDU and associated
risky practices. And fourth, the use of thin-layer chro-
matography as the form of urine analysis in this study
has potential problems in that it may produce incorrect
conclusions; it can produce both a false positive and a
Figure 2 Proportion of participants engaging in risky practices index over the 6 month TC intervention.
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of drug metabolite-like chemicals in urine and human
error. Although more expensive, more accurate tests
may want to be applied in future studies.
Although the findings of this study are specific to
Rajaee-Shahar prison in Tehran, Iran, it remains that the
Iranian prisoner “population is under-served by HIV pre-
vention services, as are the prison populations of many
countries in the Middle East and Eastern Mediterranean
regions” [12]. This recognition is transferable to other
countries in the world. As the Iranian working group on
drug treatment and rehabilitation in prison settings
shared: “We believe that Iran with the unfortunately
large addiction affliction has much to offer and in return
is eager to learn when it comes to clinical interventions
in drug abuse” [15]. Thus this study makes a contribu-
tion to both understanding harm reduction practices
within an Iranian prison and the international literature.
As correspondent Ian Tanner writes for The Majalla, an
Arab magazine, “Despite the draconian policy towards
punishing trafficking and the fact that treatment is not
universally available, Iran’s drug policy is at the very
least surprising, and perhaps even inspiring” [11].
Conclusion
The results of this study relay that the TC in Rajaee-Shahr
prison had modest immediate impact (i.e., 6 months) in
reducing high risk harmful behaviors among incarcerated
IDUs. In its current form, it is unknown if the TC would
bring about a sustainable, long-term reduction in harmful
behaviors. This is particularly important considering the
lack of significant change in knowledge and attitude re-
lated to high risk practices; the three together comprise
the Health Belief Model. Also, considering the largenumber of missed cases at follow-up, it may further in-
dicate the clinic’s benefits were either not evident or
relevant to the participants. Past studies have shown
that harm reduction initiatives are most effective when
perceived benefit is high among participants [27]. Fu-
ture research is required to determine the specific gaps
in the current TC model.
In order to combat the HIV/AIDS epidemic in Iran,
the results of this research must be considered not only
in the context of the prison environment, but beyond to
the general Iranian population [26]. The majority of the
prisoners in Rajaee-Shahr prison will be released and will
reintegrate into the general population where they have
the potential to spread HIV and other viral infections
[20]. We know from other studies that injection drug
users engage in high risk behaviors outside the prison
environment [2]. We also know that there is a need for
practice and research-focused attention to be placed on
the transition from prison to the community, and keep-
ing up safe practices such as MMT. A recent study of
HIV/AIDS in Iran emphasized “the need for intensified
HIV prevention efforts with men who use drugs via in-
jection and strengthened efforts to encourage the indi-
vidual at risk to get tested for HIV” [26]. With a large
number of IDUs filtering through the prison system in
Iran, and the high rates of HIV, HBV and HCV, this may
be an ideal catchment area. This is supported in other
studies [36,37]; in the general Iranian community, people
who wish to determine their HIV status are oftentimes
prevented from doing so because of the sociocultural con-
text. As a result, the impacts of the triangular clinic exam-
ined in this study should be supported as one part of a
broad, multi-faceted HIV/AIDS and other health behav-
iour prevention strategy in the Islamic Republic of Iran.
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